sulfadiazine has been researched along with Ocular Toxoplasmosis in 105 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravitreal injection of clindamycin and dexamethasone may be an acceptable alternative to the classic treatment in ocular toxoplasmosis." | 9.15 | Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. ( Azimzadeh, A; Dehghan, MH; Peyman, GA; Ramezani, A; Sadoughi, MM; Shahghadami, R; Soheilian, M; Yaseri, M, 2011) |
| "To compare the efficacy of the classic treatment of ocular toxoplasmosis (pyrimethamine, sulfadiazine, and prednisolone) with a regimen consisting of trimethoprim/sulfamethoxazole (co-trimoxazole) plus prednisolone." | 9.11 | Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. ( Anisian, A; Behboudi, H; Dehghan, MH; Ghajarnia, M; Peyman, GA; Sadoughi, MM; Soheilian, M; Yazdani, S, 2005) |
| "PARTICIPANTS TOTAL ENROLLMENT: 46 patients with sight-threatening ocular toxoplasmosis; pyrimethamine and azithromycin group: 24 patients; pyrimethamine and sulfadiazine group: 22 patients." | 9.10 | A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. ( Bosch-Driessen, LH; Hoyng, CB; Klok, AM; Rothova, A; Suttorp-Schulten, MS; van Ruyven, RL; Verbraak, FD, 2002) |
| "Probable hepatorenal syndrome requiring hemodialysis occurred in a patient receiving sulfadiazine for the treatment of toxoplasmosis retinitis." | 7.77 | Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine. ( Khalili, H; Soudbakhsh, A; Talasaz, AH, 2011) |
| "A 7-year-old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines." | 7.73 | Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. ( Boyer, K; Jalbrzikowski, J; Khan, AR; Latkany, P; McLeod, R; Noble, GA, 2006) |
| "Recurrences were rarely observed in the two groups: respectively 8% and 6% of cases." | 6.68 | [Value of clindamycin in the treatment of ocular toxoplasmosis]. ( Ayed, S; Azaiez, A; Bouguila, H; Daghfous, F; Jeddi, A; Kaoueche, M; Malouche, S, 1997) |
| "After 14 months' follow up, recurrences of ocular toxoplasmosis developed in both groups, 21% with clindamycin and 36% with P + S, respectively (NS)." | 6.66 | [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin]. ( Colin, J; Harie, JC, 1989) |
| "Dosing recommendations for the treatment of pregnancy-acquired toxoplasmosis are empirical and widely based on experimental data." | 5.56 | Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study. ( Enders, M; Garweg, JG; Gruetzmacher, B; Hlobil, H; Hoerauf, A; Klarmann-Schulz, U; Reiter-Owona, I; Rilling, V, 2020) |
| "Intravitreal injection of clindamycin and dexamethasone may be an acceptable alternative to the classic treatment in ocular toxoplasmosis." | 5.15 | Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. ( Azimzadeh, A; Dehghan, MH; Peyman, GA; Ramezani, A; Sadoughi, MM; Shahghadami, R; Soheilian, M; Yaseri, M, 2011) |
| "To compare the efficacy of the classic treatment of ocular toxoplasmosis (pyrimethamine, sulfadiazine, and prednisolone) with a regimen consisting of trimethoprim/sulfamethoxazole (co-trimoxazole) plus prednisolone." | 5.11 | Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. ( Anisian, A; Behboudi, H; Dehghan, MH; Ghajarnia, M; Peyman, GA; Sadoughi, MM; Soheilian, M; Yazdani, S, 2005) |
| "PARTICIPANTS TOTAL ENROLLMENT: 46 patients with sight-threatening ocular toxoplasmosis; pyrimethamine and azithromycin group: 24 patients; pyrimethamine and sulfadiazine group: 22 patients." | 5.10 | A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. ( Bosch-Driessen, LH; Hoyng, CB; Klok, AM; Rothova, A; Suttorp-Schulten, MS; van Ruyven, RL; Verbraak, FD, 2002) |
| "The purpose of this study was to estimate the frequency and describe the adverse drug reactions (ADRs) associated with the classic treatment of ocular toxoplasmosis (OT), namely sulfadiazine, pyrimethamine, corticosteroids and folinic acid." | 3.88 | Ocular toxoplasmosis: adverse reactions to treatment in a Brazilian cohort. ( Curi, ALL; Durão, NMG; Guaraldo, L; Louro, VC; Neves, ES; Quintana, MSB; Villar, BBF, 2018) |
| "Probable hepatorenal syndrome requiring hemodialysis occurred in a patient receiving sulfadiazine for the treatment of toxoplasmosis retinitis." | 3.77 | Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine. ( Khalili, H; Soudbakhsh, A; Talasaz, AH, 2011) |
| "Atypical, 100 microm to 150 microm, greyish deposits appeared along retinal arteries and veins as well as on the vitreoretinal interface in the macula of a 44-year-old Caucasian woman while she was being treated for recurrent toxoplasmic chorioretinitis with antiparasitic drugs and subconjunctival injection of betamethasone." | 3.74 | Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. ( De Potter, P; Guagnini, AP; Kozyreff, A; Levecq, L, 2007) |
| "A 7-year-old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines." | 3.73 | Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. ( Boyer, K; Jalbrzikowski, J; Khan, AR; Latkany, P; McLeod, R; Noble, GA, 2006) |
| " 1, 1973, and May 30, 1989, 36 patients (37 eyes) with ocular toxoplasmosis seen at a uveitis clinic received quadruple therapy (pyrimethamine, trisulfapyrimidines, clindamycin and prednisone)." | 3.68 | Quadruple therapy for ocular toxoplasmosis. ( Lam, S; Tessler, HH, 1993) |
| " The goal of the present paper was to study the recurrence rate of ocular toxoplasmosis during a four years period following a Pyrimethamine-sulfadiazine therapy." | 3.67 | [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment]. ( Bloch-Michel, E; Timsit, JC, 1987) |
| "Recurrences were rarely observed in the two groups: respectively 8% and 6% of cases." | 2.68 | [Value of clindamycin in the treatment of ocular toxoplasmosis]. ( Ayed, S; Azaiez, A; Bouguila, H; Daghfous, F; Jeddi, A; Kaoueche, M; Malouche, S, 1997) |
| "The mean recurrence rate after three years of follow-up was 49% for all patients (60 of 122 patients), with no differences between treated and untreated patients (P = ." | 2.67 | Therapy for ocular toxoplasmosis. ( Baarsma, GS; Boen-Tan, TN; Brinkman, CJ; Buitenhuis, HJ; de Jong, PT; Klaassen-Broekema, N; Meenken, C; Rothova, A; Schweitzer, CM; Timmerman, Z, 1993) |
| "After 14 months' follow up, recurrences of ocular toxoplasmosis developed in both groups, 21% with clindamycin and 36% with P + S, respectively (NS)." | 2.66 | [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin]. ( Colin, J; Harie, JC, 1989) |
| "Diagnosis of ocular toxoplasmosis is also discussed in the light of serological, molecular and imaging tools." | 2.48 | Ocular manifestations of systemic disease: toxoplasmosis. ( Vasconcelos-Santos, DV, 2012) |
| "Congenital toxoplasmosis was higher in mothers infected during the third pregnancy trimester, and maternal treatment during pregnancy was not associated with a lower rate of congenital toxoplasmosis." | 1.62 | Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak. ( Belfort, R; Belucik, DN; Commodaro, AG; Conceição, AR; Costa, DF; de Oliveira Dias, JR; Gustavo Brenner, L; Henrique Monteiro, M; Missio, L; Ribeiro, KS; Valadão, MCDS, 2021) |
| "Dosing recommendations for the treatment of pregnancy-acquired toxoplasmosis are empirical and widely based on experimental data." | 1.56 | Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study. ( Enders, M; Garweg, JG; Gruetzmacher, B; Hlobil, H; Hoerauf, A; Klarmann-Schulz, U; Reiter-Owona, I; Rilling, V, 2020) |
| "To present a case of congenital toxoplasmosis in a newborn whose mother had a 20-year history of a chorioretinal macular scar and positive serology for toxoplasmosis." | 1.32 | Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. ( Belfort, R; Ferreira, R; Muccioli, C; Nussenblatt, R; Silveira, C, 2003) |
| "To report a case of subfoveal choroidal neovascularization in a patient with toxoplasmic retinochoroiditis who underwent surgical excision." | 1.32 | Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. ( Adán, A; Mateo, C; Wolley-Dod, C, 2003) |
| "Both patients had a recurrence on the peripheral aspect of scars from previous retinochoroiditis and were treated with pyrimethamine (50 mg/day) and sulfadiazine (4 g/day) for seven weeks." | 1.30 | Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. ( Auer, C; Bernasconi, O; Herbort, CP, 1997) |
| "The treatment with sulfadiazine is associated with multiple side effects." | 1.30 | [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine]. ( Gümbel, H; Hacker, M; Ohrloff, C; Richter, R; Richter, T, 1998) |
| "To describe a case of severe congenital toxoplasmosis because of inadequate surveillance of a seronegative pregnant woman and to evaluate the usefulness of different microbiological diagnostic methods after birth." | 1.30 | [Analysis of a case of severe congenital toxoplasmosis]. ( Coll, O; Costa, J; Falgueras, T; Gómez-López, L; Pujol-Riqué, M; Rodríguez-Miguélez, JM; Tudó, G; Valls, ME, 1999) |
| "Macular scars were present in 54% of the treated patients; 41% were bilateral." | 1.30 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1997) |
| "Many children with congenital toxoplasmosis have substantial retinal damage at birth and consequent loss of vision." | 1.29 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1996) |
| "18 for the 50-mg/day and 25-mg/day dosage of pyrimethamine, respectively." | 1.28 | Ocular toxoplasmosis in human immunodeficiency virus-infected patients. ( Cochereau-Massin, I; Girard, B; Katlama, C; Lautier-Frau, M; LeHoang, P; Leport, C; Marcel, P; Robinet, M; Zazoun, L; Zerdoun, E, 1992) |
| "The course was further complicated by an acute renal insufficiency during treatment of the chorioretinitis with high doses sulfadiazine." | 1.28 | [One thing begets another]. ( Heydendael, RJ; Wijburg, HC, 1991) |
| "Treatment with sulfadiazine, pyrimethamine, and steroids brought about a prompt resolution." | 1.26 | Acute acquired toxoplasmosis. ( Reese, LT; Shafer, DM; Zweifach, P, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (26.67) | 18.7374 |
| 1990's | 24 (22.86) | 18.2507 |
| 2000's | 32 (30.48) | 29.6817 |
| 2010's | 18 (17.14) | 24.3611 |
| 2020's | 3 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Mouinga Abayi, DA | 1 |
| Mve Mengome, E | 1 |
| Reiter-Owona, I | 1 |
| Hlobil, H | 1 |
| Enders, M | 1 |
| Klarmann-Schulz, U | 1 |
| Gruetzmacher, B | 1 |
| Rilling, V | 1 |
| Hoerauf, A | 1 |
| Garweg, JG | 2 |
| Conceição, AR | 1 |
| Belucik, DN | 1 |
| Missio, L | 1 |
| Gustavo Brenner, L | 1 |
| Henrique Monteiro, M | 1 |
| Ribeiro, KS | 1 |
| Costa, DF | 1 |
| Valadão, MCDS | 1 |
| Commodaro, AG | 1 |
| de Oliveira Dias, JR | 1 |
| Belfort, R | 4 |
| Huang, PK | 1 |
| Jianping, C | 1 |
| Vasconcelos-Santos, DV | 2 |
| Arruda, JSD | 1 |
| Dutta Majumder, P | 1 |
| Anthony, E | 1 |
| Ganesh, SK | 2 |
| Biswas, J | 2 |
| Ling, HS | 1 |
| Teoh, SC | 1 |
| Agrawal, R | 1 |
| Loveridge-Easther, C | 1 |
| Yardley, AM | 1 |
| Breidenstein, B | 1 |
| Zhang, Y | 1 |
| Lin, X | 1 |
| Lu, F | 1 |
| Guaraldo, L | 1 |
| Villar, BBF | 1 |
| Durão, NMG | 1 |
| Louro, VC | 1 |
| Quintana, MSB | 1 |
| Curi, ALL | 1 |
| Neves, ES | 1 |
| Perrillat-Collomb, N | 1 |
| Trone, MC | 1 |
| Jullienne, R | 1 |
| Thuret, G | 1 |
| Gain, P | 1 |
| Yusuf, IH | 1 |
| Sahare, P | 1 |
| Hildebrand, GD | 1 |
| Silveira, C | 2 |
| Muccioli, C | 3 |
| Holland, GN | 4 |
| Jones, JL | 1 |
| Yu, F | 1 |
| de Paulo, A | 1 |
| Slade, H | 1 |
| Mulroy, E | 1 |
| Ussher, J | 1 |
| Putt, T | 1 |
| Schollum, J | 1 |
| Walker, R | 1 |
| Furtado, JM | 1 |
| Toscano, M | 1 |
| Castro, V | 1 |
| Rodrigues, MW | 1 |
| Pradhan, E | 1 |
| Bhandari, S | 1 |
| Gilbert, RE | 1 |
| Stanford, M | 1 |
| Morais, FB | 1 |
| Arantes, TEFE | 1 |
| Benevento, JD | 1 |
| Jager, RD | 1 |
| Noble, AG | 2 |
| Latkany, P | 3 |
| Mieler, WF | 1 |
| Sautter, M | 1 |
| Meyers, S | 2 |
| Mets, M | 3 |
| Grassi, MA | 1 |
| Rabiah, P | 2 |
| Boyer, K | 3 |
| Swisher, C | 3 |
| McLeod, R | 5 |
| Iaccheri, B | 1 |
| Fiore, T | 1 |
| Papadaki, T | 1 |
| Androudi, S | 1 |
| Janjua, S | 1 |
| Bhaila, I | 1 |
| Stephen Foster, C | 1 |
| Bowles, EC | 1 |
| Hillenius, JM | 1 |
| Biesma, DH | 1 |
| Kortbeek, LM | 1 |
| de Jongh, BM | 1 |
| Guex-Crosier, Y | 2 |
| Lopes, CD | 1 |
| Silva, NM | 1 |
| Ferro, EA | 1 |
| Sousa, RA | 1 |
| Firminot, ML | 1 |
| Bernardes, ES | 1 |
| Roque-Barreira, MC | 1 |
| Pena, JD | 1 |
| Adán, A | 2 |
| Sole, M | 1 |
| Mateo, C | 2 |
| Jean, AS | 1 |
| Alforja, S | 1 |
| Soheilian, M | 2 |
| Ramezani, A | 1 |
| Azimzadeh, A | 1 |
| Sadoughi, MM | 2 |
| Dehghan, MH | 2 |
| Shahghadami, R | 1 |
| Yaseri, M | 1 |
| Peyman, GA | 2 |
| Ajzenberg, D | 1 |
| Khalili, H | 1 |
| Soudbakhsh, A | 1 |
| Talasaz, AH | 1 |
| Balaskas, K | 1 |
| Vaudaux, J | 1 |
| Boillat-Blanco, N | 1 |
| Jad, A | 1 |
| Céline, T | 1 |
| Bahram, B | 1 |
| Phuc, L | 1 |
| Nathalie, C | 1 |
| Anghel, G | 1 |
| Wolley-Dod, C | 1 |
| Conrath, J | 1 |
| Mouly-Bandini, A | 1 |
| Collart, F | 1 |
| Ridings, B | 1 |
| Banta, JT | 1 |
| Davis, JL | 1 |
| Lam, BL | 1 |
| Ferreira, R | 1 |
| Nussenblatt, R | 1 |
| Brady-McCreery, KM | 1 |
| Hussein, MA | 1 |
| Paysse, EA | 1 |
| JACOBS, L | 1 |
| MELTON, ML | 1 |
| KAUFMAN, HE | 1 |
| FRANCOIS, J | 1 |
| JADIN, J | 1 |
| WERY, M | 1 |
| VANDECASTEELE, J | 1 |
| GILES, CL | 2 |
| ALEXANDER, M | 2 |
| Perrotta, S | 1 |
| Nobili, B | 1 |
| Grassia, C | 1 |
| Sebastiani, A | 1 |
| Parmeggiani, F | 1 |
| Costagliola, C | 1 |
| Sharma, S | 1 |
| Narayana, KM | 1 |
| Ghajarnia, M | 1 |
| Yazdani, S | 1 |
| Behboudi, H | 1 |
| Anisian, A | 1 |
| Di Carlo, P | 1 |
| Mazzola, A | 1 |
| Romano, A | 1 |
| Schimmenti, MG | 1 |
| Colicchia, P | 1 |
| Bellipanni, P | 1 |
| Titone, L | 1 |
| Russo, M | 1 |
| Pergola, G | 1 |
| Pedicini, G | 1 |
| Khan, AR | 1 |
| Noble, GA | 1 |
| Jalbrzikowski, J | 2 |
| Lee, MW | 1 |
| Fong, KS | 1 |
| Hsu, LY | 1 |
| Lim, WK | 1 |
| Guagnini, AP | 1 |
| De Potter, P | 1 |
| Levecq, L | 1 |
| Kozyreff, A | 1 |
| Low, SC | 1 |
| Chan, LL | 1 |
| Gonçalves, RM | 1 |
| Rodrigues, DH | 1 |
| Camargos da Costa, AM | 1 |
| Teixeira, MM | 1 |
| Ribeiro Campos, W | 1 |
| Oréfice, F | 1 |
| Teixeira, AL | 1 |
| Phan, L | 1 |
| Kasza, K | 1 |
| Kuo, A | 1 |
| Mieler, W | 1 |
| Roizen, N | 4 |
| Cezar, S | 1 |
| Remington, J | 1 |
| Meier, P | 3 |
| Palkovacs, EM | 1 |
| Correa, Z | 1 |
| Augsburger, JJ | 1 |
| Eagle, RC | 1 |
| Durquety, MC | 1 |
| Verin, P | 1 |
| Le Rebeller, MJ | 1 |
| Lakhanpal, V | 1 |
| Schocket, SS | 1 |
| Nirankari, VS | 1 |
| Guldsten, H | 1 |
| McCabe, RE | 1 |
| Remington, JS | 3 |
| Ghartey, KN | 1 |
| Brockhurst, RJ | 1 |
| Reese, LT | 1 |
| Shafer, DM | 1 |
| Zweifach, P | 1 |
| Abrahams, IW | 1 |
| Gregerson, DS | 1 |
| Murphy, GE | 1 |
| Couvreur, J | 1 |
| Nottin, N | 1 |
| Desmonts, G | 1 |
| Tabbara, KF | 1 |
| O'Connor, GR | 1 |
| Robinson, RO | 1 |
| Baumann, RJ | 1 |
| Peacock, JE | 1 |
| Greven, CM | 1 |
| Cruz, JM | 1 |
| Hurd, DD | 1 |
| McAuley, J | 1 |
| Boyer, KM | 3 |
| Patel, D | 3 |
| Wolters, C | 1 |
| Stein, L | 3 |
| Stein, M | 3 |
| Schey, W | 1 |
| Mittelviefhaus, H | 1 |
| Rothova, A | 2 |
| Meenken, C | 1 |
| Buitenhuis, HJ | 1 |
| Brinkman, CJ | 1 |
| Baarsma, GS | 1 |
| Boen-Tan, TN | 1 |
| de Jong, PT | 1 |
| Klaassen-Broekema, N | 1 |
| Schweitzer, CM | 1 |
| Timmerman, Z | 1 |
| Lam, S | 1 |
| Tessler, HH | 1 |
| Wei, ME | 1 |
| Campbell, SH | 1 |
| Taylor, C | 1 |
| Mets, MB | 2 |
| Holfels, E | 2 |
| Swisher, CN | 2 |
| Hopkins, J | 2 |
| Withers, S | 2 |
| Mack, D | 2 |
| Luciano, R | 2 |
| Morhun, PJ | 1 |
| Weisz, JM | 1 |
| Elias, SJ | 1 |
| Hayashi, S | 1 |
| Kim, MK | 1 |
| Jeddi, A | 1 |
| Azaiez, A | 1 |
| Bouguila, H | 1 |
| Kaoueche, M | 1 |
| Malouche, S | 1 |
| Daghfous, F | 1 |
| Ayed, S | 1 |
| Bernasconi, O | 2 |
| Auer, C | 2 |
| Herbort, CP | 2 |
| Brinkman, K | 1 |
| Debast, S | 1 |
| Sauerwein, R | 1 |
| Ooyman, F | 1 |
| Hiel, J | 1 |
| Raemaekers, J | 1 |
| Hacker, M | 1 |
| Richter, R | 1 |
| Gümbel, H | 1 |
| Richter, T | 1 |
| Ohrloff, C | 1 |
| Ysasaga, JE | 1 |
| Davis, J | 1 |
| Pujol-Riqué, M | 1 |
| Gómez-López, L | 1 |
| Tudó, G | 1 |
| Falgueras, T | 1 |
| Costa, J | 1 |
| Rodríguez-Miguélez, JM | 1 |
| Coll, O | 1 |
| Valls, ME | 1 |
| Jacquier, P | 1 |
| Boehnke, M | 1 |
| Chiquet, C | 1 |
| Fleury, J | 1 |
| Blanc-Jouvan, M | 1 |
| Wallon, M | 1 |
| Boibieux, A | 1 |
| Figueroa, MS | 1 |
| Bou, G | 1 |
| Marti-Belda, P | 1 |
| Lopez-Velez, R | 1 |
| Guerrero, A | 1 |
| Smith, JM | 1 |
| Curi, AL | 1 |
| Pavesio, CE | 1 |
| Lightman, S | 1 |
| Lynn, WA | 1 |
| Morand, JJ | 1 |
| Lightburn, E | 1 |
| Coton, T | 1 |
| Carré, D | 1 |
| Chouc, C | 1 |
| Debonne, JM | 1 |
| Jean-Pastor, MJ | 1 |
| Bosch-Driessen, LH | 1 |
| Verbraak, FD | 1 |
| Suttorp-Schulten, MS | 1 |
| van Ruyven, RL | 1 |
| Klok, AM | 1 |
| Hoyng, CB | 1 |
| Gump, DW | 1 |
| Holden, RA | 1 |
| Zhang, MH | 1 |
| Yang, HZ | 1 |
| Cochereau-Massin, I | 1 |
| LeHoang, P | 1 |
| Lautier-Frau, M | 1 |
| Zerdoun, E | 1 |
| Zazoun, L | 2 |
| Robinet, M | 1 |
| Marcel, P | 1 |
| Girard, B | 1 |
| Katlama, C | 1 |
| Leport, C | 2 |
| Geier, B | 1 |
| Nousbaum, JP | 1 |
| Cauvin, JM | 1 |
| Rosaszkiewick, M | 1 |
| Gouérou, H | 1 |
| Iannucci, AA | 1 |
| Hart, LL | 1 |
| Wijburg, HC | 1 |
| Heydendael, RJ | 1 |
| Hausmann, N | 1 |
| Richard, G | 1 |
| Chakroun, M | 1 |
| Meyohas, MC | 1 |
| Pelosse, B | 1 |
| Vacherot, B | 1 |
| Derouin, F | 1 |
| Colin, J | 1 |
| Harie, JC | 1 |
| Malla, N | 1 |
| Goyal, M | 1 |
| Pillai, P | 1 |
| Ganguly, NK | 1 |
| Mahajan, RC | 1 |
| Timsit, JC | 1 |
| Bloch-Michel, E | 1 |
| Rifaat, MA | 2 |
| Sadek, MS | 2 |
| el-Naggar, BA | 2 |
| Munir, AM | 2 |
| Hogan, MJ | 2 |
| Siim, JC | 1 |
| Linton, RG | 1 |
| Sedan, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Trimethoprim-sulfamethoxazole for the Recurrence of Retinochoroiditis Toxoplasma Gondii[NCT01449877] | Phase 3 | 141 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for sulfadiazine and Ocular Toxoplasmosis
| Article | Year |
|---|---|
Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Bayes Theorem; Clindamycin; Female; Humans; Immunocompromised Host; | 2018 |
Antibiotics versus no treatment for toxoplasma retinochoroiditis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Child; Chorioretinitis; Drug Combinations; Human | 2016 |
Ocular manifestations of systemic disease: toxoplasmosis.
Topics: Humans; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Ocular; Uveitis, Posterior | 2012 |
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
Topics: Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents | 1995 |
[Treatment of ocular toxoplasmosis. Part 2: Therapeutic approaches].
Topics: Child; Clindamycin; Coccidiostats; Contraindications; Dose-Response Relationship, Drug; Drug Adminis | 1993 |
Clindamycin in the treatment of toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Humans; Pyrimethamine; Retrospective Studies; Sulfa | 1992 |
Ocular toxoplasmosis.
Topics: Abortion, Spontaneous; Adult; Animals; Diagnosis, Differential; Eye Diseases; Female; Humans; Hypers | 1969 |
8 trials available for sulfadiazine and Ocular Toxoplasmosis
| Article | Year |
|---|---|
Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Clindamycin; Dexamethasone; Drug Therapy, Combin | 2011 |
Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.
Topics: Adult; Antiprotozoal Agents; Azithromycin; Chorioretinitis; Female; Humans; Male; Middle Aged; Pilot | 2012 |
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Child; Chorioretinitis; Dru | 2005 |
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
Topics: Animals; Calcinosis; Chemistry, Pharmaceutical; Child; Child, Preschool; Drug Administration Schedul | 1994 |
Therapy for ocular toxoplasmosis.
Topics: Adult; Chorioretinitis; Clindamycin; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocort | 1993 |
[Value of clindamycin in the treatment of ocular toxoplasmosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Chorioretinitis; Clindamycin | 1997 |
A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromyci | 2002 |
[Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Topics: Acute Disease; Adolescent; Adult; Child; Chorioretinitis; Clindamycin; Drug Therapy, Combination; Fe | 1989 |
90 other studies available for sulfadiazine and Ocular Toxoplasmosis
| Article | Year |
|---|---|
[A macular retinal serous detachment complicating a toxoplasmic retinochorioditis].
Topics: Chorioretinitis; Drug Administration Schedule; Female; Fluorescein Angiography; Fundus Oculi; Humans | 2020 |
Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Topics: Adolescent; Adult; Antiprotozoal Agents; Case-Control Studies; Drug Therapy, Combination; Female; Hu | 2020 |
Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Disease Outbreaks; DNA, Protozoan; Drug Therapy, Combin | 2021 |
Ocular Toxoplasmosis in Tropical Areas: Analysis and Outcome of 190 Patients from a Multicenter Collaborative Study.
Topics: Adolescent; Adult; Aged; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Femal | 2018 |
Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis.
Topics: Antiprotozoal Agents; DNA, Protozoan; Drug Therapy, Combination; Early Diagnosis; Electroencephalogr | 2018 |
Ocular toxoplasmosis: adverse reactions to treatment in a Brazilian cohort.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidotes | 2018 |
[Intravitreal injections of clindamycin and dexamethasone in the management of bilateral toxoplasmosis case complicated by DRESS syndrome].
Topics: Aged; Clindamycin; Dexamethasone; Drug Hypersensitivity Syndrome; Drug Substitution; Female; Humans; | 2018 |
DRESS syndrome in a child treated for toxoplasma retinochoroiditis.
Topics: Adolescent; Antiprotozoal Agents; Chorioretinitis; Drug Eruptions; Drug Hypersensitivity; Drug Thera | 2013 |
Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Protozoan; Antiprotozoal Agents; Brazil; Chi | 2015 |
Sulfadiazine-induced crystal nephropathy: a new 'old' problem.
Topics: Antiprotozoal Agents; Crystallization; Humans; Kidney Diseases; Male; Middle Aged; Sulfadiazine; Tox | 2015 |
Roth Spots in Ocular Toxoplasmosis.
Topics: Antiprotozoal Agents; Chorioretinitis; Diagnosis, Differential; Drug Therapy, Combination; Humans; I | 2016 |
Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists.
Topics: Anti-Bacterial Agents; Brazil; Glucocorticoids; Health Surveys; Humans; Ophthalmology; Practice Patt | 2018 |
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiprotozoal Agents; Child; Choro | 2008 |
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse | 2008 |
[Postnatal ocular toxoplasmosis in a grown woman].
Topics: Coccidiostats; Drug Therapy, Combination; Female; Folic Acid; Humans; Middle Aged; Prednisone; Pyrim | 2009 |
Update on the treatment of ocular toxoplasmosis.
Topics: Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Humans; Photochemo | 2009 |
Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Azithromycin; Brain; Disease Models, Animal; D | 2009 |
Cytologic identification of Toxoplasma gondii from subretinal aspirate.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Drug Therapy, Combination; Fluorescein Angiography; Glu | 2012 |
Unresolved questions about the most successful known parasite.
Topics: Animals; Child, Preschool; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertica | 2011 |
Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine.
Topics: Antiprotozoal Agents; Female; Hepatorenal Syndrome; Humans; Liver; Outcome Assessment, Health Care; | 2011 |
Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Female; Fuchs' Endothelial Dystrophy; Fundus | 2013 |
[Clinical and therapy features of ocular toxoplasmosis in patients with HIV-AIDS infection].
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Folic Ac | 2002 |
Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis.
Topics: Adult; Antiprotozoal Agents; Chorioretinitis; Choroidal Neovascularization; Drug Therapy, Combinatio | 2003 |
Toxoplasma gondii retinochoroiditis after cardiac transplantation.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretinitis; Drug Therapy, Combination; Enzy | 2003 |
Presumed toxoplasmosic anterior optic neuropathy.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male | 2002 |
Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier.
Topics: Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; | 2003 |
Congenital toxoplasmosis with unusual retinal findings.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, | 2003 |
TREATMENT OF EXPERIMENTAL OCULAR TOXOPLASMOSIS.
Topics: Animals; Dapsone; Eye; Guinea Pigs; Head; Pyrimethamine; Rabbits; Research; Sulfadiazine; Toxoplasmo | 1964 |
[TREATMENT OF TOXOPLASMOSIS. (EXPERIMENTAL STUDY)].
Topics: Anilides; Animals; Anti-Bacterial Agents; Colistin; Mice; Oxytetracycline; Penicillin V; Pyrimethami | 1963 |
THE TREATMENT OF TOXOPLASMA UVEITIS.
Topics: Adrenal Cortex Hormones; Blood Platelets; Drug Therapy; Erythrocyte Count; Hematocrit; Hemoglobinome | 1964 |
[TOXOPLASMOSIS IN ADULTS].
Topics: Adult; Diagnosis; Encephalomyelitis; Female; Humans; Meningoencephalitis; Pregnancy; Pregnancy Compl | 1965 |
Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Child; Drug Therapy, Combination; Enzyme-Linke | 2003 |
Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
Topics: Adult; Age Distribution; Antiprotozoal Agents; Chorioretinitis; Drug Therapy, Combination; Female; G | 2004 |
Fuchs' heterochromic iridocyclitis following bilateral ocular toxoplasmosis.
Topics: Adult; Antiprotozoal Agents; Atrophy; Clindamycin; Drug Therapy, Combination; Female; Humans; Iridoc | 2004 |
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Topics: Adolescent; Adult; Amniocentesis; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretini | 2005 |
Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
Topics: Antiprotozoal Agents; Humans; Prospective Studies; Pyrimethamine; Randomized Controlled Trials as To | 2005 |
[Ocular toxoplasmosis: our experience].
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Chorioretinitis; Drug Therapy, Combination; Female; H | 2005 |
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
Topics: Animals; Antiprotozoal Agents; Child; Chorioretinitis; Drug Hypersensitivity; Drug Therapy, Combinat | 2006 |
Optic nerve toxoplasmosis and orbital inflammation as initial presentation of AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Blepharitis; CD4 Lymphocyte Count; Co | 2006 |
Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis.
Topics: Adult; Antiprotozoal Agents; Betamethasone; Chorioretinitis; Drug Therapy, Combination; Female; Gluc | 2007 |
MRI of ocular toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimethamine; | 2006 |
Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Antiprotozoal Agents; Chorioretinitis; Female; Human | 2007 |
Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; | 2008 |
Acquired toxoplasmic retinitis in an immunosuppressed patient: diagnosis by transvitreal fine-needle aspiration biopsy.
Topics: Adult; Antiprotozoal Agents; Biopsy, Fine-Needle; Bone Marrow Transplantation; Drug Therapy, Combina | 2008 |
[Influence of the treatment on humoral immunity in toxoplasmosis].
Topics: Antibody Formation; Child; Drug Therapy, Combination; Female; Humans; Leucomycins; Male; Pyrimethami | 1984 |
Clindamycin in the treatment of toxoplasmic retinochoroiditis.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Chorioretinitis; Clindamycin; Drug Therapy, Combinati | 1983 |
Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis.
Topics: Adolescent; Adult; Child; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Fluores | 1983 |
The diagnosis and treatment of toxoplasmosis.
Topics: Adult; Anti-Bacterial Agents; Antibodies; Antigens; Child; Female; Humans; Immunologic Deficiency Sy | 1983 |
Photocoagulation of active toxoplasmic retinochoroiditis.
Topics: Adolescent; Adult; Chorioretinitis; Chronic Disease; Drug Therapy, Combination; Female; Humans; Leuc | 1980 |
Acute acquired toxoplasmosis.
Topics: Brain Diseases; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Middle Aged; Pyrimethami | 1981 |
Longitudinal study of serum antibody responses to retinal antigens in acute ocular toxoplasmosis.
Topics: Adult; Animals; Antibodies; Antigens; Cattle; Clindamycin; Female; Humans; Immunologic Techniques; R | 1982 |
Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.
Topics: Adult; Chorioretinitis; Clindamycin; Drug Therapy, Combination; Female; Humans; Pyrimethamine; Recur | 1982 |
[Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Chorioretinitis; Drug Therapy, Combination; Follow-Up Studies; | 1980 |
Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine.
Topics: Adolescent; Adult; Clindamycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; | 1980 |
Late cerebral relapse of congenital toxoplasmosis.
Topics: Child; Chorioretinitis; Drug Therapy, Combination; Encephalitis; Female; Humans; Pyrimethamine; Recu | 1980 |
Quadruple therapy for ocular toxoplasmosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clindamycin; Drug Administration Schedule; Drug Co | 1993 |
Precipitous visual loss secondary to optic nerve toxoplasmosis as an unusual presentation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therap | 1996 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1996 |
Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids.
Topics: Adolescent; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Protozoan; Antidot | 1996 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Choroid Diseases; Cicatrix; Femal | 1997 |
White-centered retinal hemorrhages in ocular toxoplasmosis.
Topics: Adult; Anti-Infective Agents; Chorioretinitis; Female; Fluorescein Angiography; Fundus Oculi; Glucoc | 1997 |
Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography.
Topics: Adult; Angiography; Anti-Infective Agents; Chorioretinitis; Coloring Agents; Female; Fluorescein Ang | 1997 |
Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Clindamycin; Female; Graft vs Host Diseas | 1998 |
[Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
Topics: Adult; Breast Feeding; Chorioretinitis; Dose-Response Relationship, Drug; Drug Administration Schedu | 1998 |
Indocyanine green angiography features in toxoplasmic retinochoroiditis.
Topics: Acute Disease; Antiprotozoal Agents; Chorioretinitis; Choroid; Drug Therapy, Combination; Female; Fl | 1999 |
Frosted branch angiitis with ocular toxoplasmosis.
Topics: Adolescent; Animals; Antibodies, Protozoan; Chorioretinitis; Drug Therapy, Combination; Enzyme-Linke | 1999 |
[Analysis of a case of severe congenital toxoplasmosis].
Topics: Acute Disease; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antibodies, Protoz | 1999 |
Early aqueous humor analysis in patients with human ocular toxoplasmosis.
Topics: Animals; Antibodies, Protozoan; Antibody Formation; Antibody Specificity; Antiprotozoal Agents; Aque | 2000 |
[Acquired ocular toxoplasmosis (panuveitis) after liver transplantation].
Topics: Adult; Antiprotozoal Agents; Female; Fluorescein Angiography; Humans; Liver Transplantation; Postope | 2000 |
Diagnostic value of polymerase chain reaction in blood and aqueous humor in immunocompetent patients with ocular toxoplasmosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antiprotozoal Agents; Aqueous Humor; Blotting, Southern; DN | 2000 |
Crystalluria with sulphadiazine.
Topics: Adult; Coccidiostats; Female; Humans; Sulfadiazine; Toxoplasmosis, Ocular; Urinary Calculi | 2001 |
Clinical microbiological case: visual problems in an HIV-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Antiretroviral Therapy, | 2001 |
[Drug hypersensitivity syndrome rapidly resolving after human immunoglobulin infusion].
Topics: Adult; Chemical and Drug Induced Liver Injury; Coccidiostats; Drug Eruptions; Drug Hypersensitivity; | 2001 |
Acquired chorioretinitis due to toxoplasmosis.
Topics: Adult; Chorioretinitis; Drug Combinations; Humans; Male; Pyrimethamine; Sulfadiazine; Toxoplasmosis, | 1979 |
[Toxoplasmic retinochoroiditis].
Topics: Adolescent; Adult; Aged; Child; Chorioretinitis; Drug Therapy, Combination; Female; Humans; Male; Mi | 1992 |
Ocular toxoplasmosis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Clindamycin; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up S | 1992 |
[Acute hepatitis probably secondary to the treatment with pyrimethamine-sulfadiazine combination].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Mal | 1992 |
[One thing begets another].
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Boutonneuse Fever; Chorioretinitis; Drug The | 1991 |
Acquired ocular toxoplasmosis. A fluorescein angiography study.
Topics: Adult; Animals; Antibodies, Protozoan; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Hum | 1991 |
[Ocular toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Humans; Male; Middle Aged; Opportunistic | 1990 |
Experimental ocular toxoplasmosis with RH strain of Toxoplasma gondii.
Topics: Animals; Disease Models, Animal; Rabbits; Sulfadiazine; Toxoplasmosis, Ocular | 1988 |
[Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Chorioretinitis; Drug Therapy, Combination; Femal | 1987 |
A case of toxoplasmic uveitis treated with pyrimethamine and sulpha drugs in Egypt (case report).
Topics: Adolescent; Edema; Female; Headache; Hemorrhage; Humans; Ophthalmoscopy; Pyrimethamine; Sulfadiazine | 1973 |
A case of toxoplasmic uveitis treated with pyrimethamine and sulpha drugs in Egypt (case report).
Topics: Adolescent; Chorioretinitis; Egypt; Female; Humans; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Ocul | 1973 |
[Acquired toxoplasmosis].
Topics: Adult; Animals; Child; Diagnosis, Differential; Female; Humans; Lymphadenitis; Mice; Pregnancy; Pyri | 1971 |
The treatment of toxoplasmic posterior uveitis (chorioretinitis).
Topics: Adrenal Cortex Hormones; Chorioretinitis; Humans; Leucovorin; Pyrimethamine; Sulfadiazine; Toxoplasm | 1966 |
[Ocular toxoplasmosis].
Topics: Diagnosis, Differential; Eye; Female; Humans; Leucovorin; Prednisone; Pregnancy; Pregnancy Complicat | 1968 |
Prophylactic treatment of recurrent attacks of uveitis due to I. toxoplasmosis and 2. streptococci.
Topics: Chronic Disease; Humans; Penicillins; Prednisolone; Pyrimethamine; Streptococcal Infections; Sulfadi | 1969 |
[Epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Administration, Oral; Adult; Animals; Child; Complement Fixation Tests; Diagnosis, Differential; Fem | 1970 |
[Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
Topics: Folic Acid; Humans; Leucomycins; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Congenital; Toxoplasmos | 1967 |